Covid molecular testing to detect active infections

Chennai: Neuberg Diagnostics, a global laboratory testing group, has announced the start of its clinical laboratory operations in North Carolina in the United States of America (USA).

The laboratory will focus on genomic and molecular testing based on new generation sequencing techniques.

NCGM has introduced Covid-19 molecular testing to detect active SARS CoV-2 virus infections that is of immediate public health priority in North America, along with genome scale testing, such as Exome Sequencing, which is applicable across a variety of Rare Genetic Disease Testing (Inherited Diseases) from Newborn Screening to Oncology to Pediatric Care Setting.